Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML. | Am J Cancer Res;13(9): 3921-3940, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.

Du, Ashuai; Yang, Qinglong; Luo, Xinhua.

Affiliation

Du A; Department of Infectious Diseases, Guizhou Provincial People's Hospital Guiyang 550002, Guizhou, China.
Yang Q; Department of General Surgery, Guizhou Provincial People's Hospital Guiyang 550002, Guizhou, China.
Luo X; Department of Infectious Diseases, Guizhou Provincial People's Hospital Guiyang 550002, Guizhou, China.

Am J Cancer Res ; 13(9): 3921-3940, 2023.

Article in En | MEDLINE | ID: mdl-37818049

Key words

Acute myeloblastic leukemia; CDKN2A; HAGLR; cuproptosis; elesclomol; miR-326

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2023 Type: Article Affiliation country: China

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2023 Type: Article Affiliation country: China